LIVE FROM SEC EDGAR
Every SEC filing that moves stocks, the minute it lands.
Earnings, insider buys and sells, 5% stakes, IPO filings and red flags, summarized in plain English.
8-KInsider
5% stakeIPORed flag
center = newest
Filings per hour last 24 hours
Minerva Neurosciences, Inc.NERV · Nov 6, 9:10 AM ET
Minerva reports $100.7 million Q3 net income from $109.6 million warrant gain
Minerva Neurosciences reported third quarter 2026 GAAP net income of $100.7 million, driven by a $109.6 million non-cash warrant liability gain, while its confirmatory Phase 3 roluperidone trial continues with topline Phase A data expected in 2H 2027.
AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.